We only have this paper's title and publication details.
Read it at the sourceRandomized trials show dupilumab improves efficacy and safety in adults with prurigo nodularis, highlighting its role in treatment.
ClinicalTrials.gov Identifiers: NCT04183335 and NCT04202679.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: